Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease
1988
We determined the serum concentration of the C-terminal propertide of type I procollagen (pColl-I-C) in 60 children and adolescents (ages 4 to 17 years) with inflammatory bowel disease (24 ulcerative colitis, 36 Crohn disease) and in seven children (ages 2 to 15 years) with nongastrointestinal disease (asthma) during varying regimens of corticosteroid therapy. Patients with inflammatory bowel disease were grouped according to disease severity (mild, and moderate to severe). Significantly lower pColl-I-C concentrations and growth velocities were found in each severity group among those subjects receiving daily corticosteroid therapy compared with those receiving alternate-day or no corticosteroid therapy (P
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
22
References
54
Citations
NaN
KQI